arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Inventiva S.A.

IVA Health Care Biotechnology: Pharmaceutical Preparations
$3.71
▲ +4.5% Today
as of Oct 23, 16:49 ET
Last 30 days -4.38% Sep 14 → Oct 23
$2.79 $3.08 $3.38 $3.67 $3.96 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.55
High
$3.76
Low
$3.48
Volume
$5M
Avg Vol
$898,124
Mkt Cap
$815M
P/E (TTM)
—
Beta
—
52w High
$7.98
52w Low
$2.82
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 13 items

Oct 6 · 20:05 PR GlobeNewswire
Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026
Oct 4 · 19:26 Insider Monkey
Inventiva (IVA): How Much Is One Make-or-Break Readout Really Worth?
Oct 4 · 05:02 MarketBeat
Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test
▸ Show all 13 press releases & news Free account →

IVA earnings at a glance

The options market is pricing a move of about ±50.5% after the report, a range of roughly $1.84 to $5.58 from today's $3.71. Implied volatility is currently 403%. The share price of $3.71 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.82
$7.98
17% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
403%
EM ±50.5% · $3 · Oct 16

Earnings trends

Implied volatility — last 90 days

38%460%883%1305%1728% Jun 15 — IV 1728% · EM ±125.0%Jun 24 — IV 794% · EM ±159.0%Jun 25 — IV 744% · EM ±145.7%Jul 07 — IV 524% · EM ±69.2%Jul 20 — IV 513% · EM ±121.2%Jul 21 — IV 38% · EM ±8.9%Jul 22 — IV 125% · EM ±28.6%Jul 23 — IV 128% · EM ±28.8%Jul 24 — IV 66% · EM ±14.6%Jul 27 — IV 318% · EM ±66.3%Jul 28 — IV 84% · EM ±17.2%Jul 29 — IV 100% · EM ±20.0%Jul 31 — IV 437% · EM ±83.7%Aug 03 — IV 482% · EM ±85.5%Aug 05 — IV 70% · EM ±11.7%Aug 10 — IV 160% · EM ±22.1%Aug 11 — IV 168% · EM ±22.2%Aug 12 — IV 102% · EM ±12.8%Aug 13 — IV 193% · EM ±22.8%Aug 17 — IV 166% · EM ±13.8%Aug 24 — IV 423% · EM ±88.3%Aug 25 — IV 47% · EM ±9.6%Aug 26 — IV 41% · EM ±8.3%Aug 28 — IV 400% · EM ±76.5%Sep 02 — IV 434% · EM ±72.4%Sep 03 — IV 141% · EM ±22.7%Sep 04 — IV 469% · EM ±73.2%Sep 07 — IV 529% · EM ±73.2%Sep 10 — IV 712% · EM ±84.1%Sep 24 — IV 900% · EM ±176.4%Sep 25 — IV 761% · EM ±145.6%Oct 01 — IV 858% · EM ±138.7%Oct 02 — IV 761% · EM ±118.9%Oct 06 — IV 1007% · EM ±132.9%Oct 07 — IV 403% · EM ±50.5%

Sector peers

ESPR
Esperion Therapeutics, Inc.
$819M $3.18
LXRX
Lexicon Pharmaceuticals, Inc.
$783M $1.42-9.0%
WVE
Wave Life Sciences, Inc.
$765M $3.18-5.6%
HELP
Helus Pharma Inc.
$870M $10.19-5.5%
CRVS
Corvus Pharmaceuticals, Inc.
$876M $10.53+4.8%
JBIO
Jade Biosciences, Inc.
$876M $14.59-3.6%

IVA earnings FAQ

What is IVA's expected move for earnings?

Options currently price a move of about ±50.5%, or $1.87 per share either way from $3.71.

What is IVA's implied volatility?

IVA's at-the-money implied volatility is about 403% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in